摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

tert-butyl-1,5-dimethyl citrate | 114340-51-1

中文名称
——
中文别名
——
英文名称
tert-butyl-1,5-dimethyl citrate
英文别名
2-tert-butyl 1,3-dimethyl 2-hydroxypropane-1,2,3-tricarboxylate;dimethyl 3-(tert-butoxycarbonyl)-3-hydroxypentanedioate;3-tert-butyl 1,5-dimethyl citrate;2-O-tert-butyl 1-O,3-O-dimethyl 2-hydroxypropane-1,2,3-tricarboxylate
tert-butyl-1,5-dimethyl citrate化学式
CAS
114340-51-1
化学式
C12H20O7
mdl
——
分子量
276.287
InChiKey
PWSGVJPWIKGYHZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    284.4±7.0 °C(Predicted)
  • 密度:
    1.177±0.06 g/cm3(Predicted)
  • 溶解度:
    可溶于乙酸乙酯、甲醇

计算性质

  • 辛醇/水分配系数(LogP):
    0
  • 重原子数:
    19
  • 可旋转键数:
    9
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    99.1
  • 氢给体数:
    1
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Rapid-acting insulin composition comprising a substituted citrate
    申请人:ADOCIA
    公开号:US20170136097A1
    公开(公告)日:2017-05-18
    A composition, in the form of an aqueous solution, including an insulin in hexameric form and at least one substituted citrate of formula I: in which: R 1 , R 2 , R 3 , identical or different, represent OH or AA, at least one of the R 1 , R 2 , R 3 is an AA radical, AA is a radical resulting from a natural or synthetic aromatic amino acid comprising at least one phenyl group or indole group, substituted or not substituted, said AA radical having at least one free carboxylic acid function, and the carboxylic acid functions are in the form of a salt of an alkali metal selected from Na + and K + .
    一种组合物,以溶液的形式存在,包括六聚体形式的胰岛素和至少一种式I的取代柠檬酸盐:其中:R1、R2、R3,相同或不同,代表OH或AA,R1、R2、R3中至少有一个是AA基团,AA是由天然或合成的芳香氨基酸组成的基团,包括至少一个苯基或吲哚基,取代或未取代,所述AA基团具有至少一个自由羧酸功能基团,羧酸功能基团以Na+和K+中选择的碱属的盐形式存在。
  • Comparison of human glutamate carboxypeptidases II and III reveals their divergent substrate specificities
    作者:Michal Navrátil、Jan Tykvart、Jiří Schimer、Petr Pachl、Václav Navrátil、Tibor András Rokob、Klára Hlouchová、Lubomír Rulíšek、Jan Konvalinka
    DOI:10.1111/febs.13761
    日期:2016.7
    UNLABELLED Glutamate carboxypeptidase III (GCPIII) is best known as a homologue of glutamate carboxypeptidase II [GCPII; also known as prostate-specific membrane antigen (PSMA)], a protease involved in neurological disorders and overexpressed in a number of solid cancers. However, mouse GCPIII was recently shown to cleave β-citrylglutamate (BCG), suggesting that these two closely related enzymes have
    未标记的谷酸羧肽酶 III (GCPIII) 是众所周知的谷酸羧肽酶 II [GCPII; 也称为前列腺特异性膜抗原 (PSMA)],一种涉及神经系统疾病并在许多实体癌中过度表达的蛋白酶。然而,最近显示小鼠 GCPIII 可裂解 β-柠檬酸酸 (BCG),表明这两种密切相关的酶具有不同的功能。为了开发一种工具来剖析、评估和量化人类 GCPII 和 GCPIII 的活性,我们分析了这些酶对三种生理底物的催化效率。我们观察到 GCPIII 但不是 GCPII 的 BCG 裂解效率高。我们还确定了二价阳离子对 GCPIII 酶活性的强烈调节,而我们没有观察到 GCPII 的这种影响。此外,我们使用 X 射线晶体学和计算模型(量子和分子力学计算)来描述 BCG 分别与 GCPII 和 GCPIII 的活性位点结合的机制。最后,我们利用 GCPII 和 GCPIII 对其底物的酶促效率的显着
  • Synthesis of Biosynthetic Intermediates of Vibrioferrin and Enzyme Reactions Using Them as Substrates
    作者:Hidemichi Mitome、Tomotaka Tanabe、Tatsuya Funahashi、Kazuki Akira
    DOI:10.1248/cpb.c24-00168
    日期:2024.6.14
    alanine-2-amidoethyl citrate were respectively synthesized as a mixture of stereoisomers. These compounds were used as substrates for enzyme reactions using recombinant PvsA, PvsB, and PvsE proteins as corresponding enzyme equivalents. The results of our study show that each enzyme reacts with a respective substrate and produces VF along the proposed biosynthetic pathway. Furthermore, the results of this study will
    分别合成了载体弧铁蛋白(VF)、 O-柠檬酰-L-丝氨酸柠檬酸2-乙酯柠檬酸酸-2-乙酯生物合成中间体,作为立体异构体的混合物。这些化合物用作酶反应的底物,使用重组 PvsA、PvsB 和 PvsE 蛋白作为相应的酶等价物。我们的研究结果表明,每种酶与各自的底物发生反应,并沿着所提出的生物合成途径产生 VF。此外,这项研究的结果将有助于了解 VF 生物合成酶,并可能有助于通过抑制载体生物合成酶来开发抗菌药物。  全尺寸图像
  • Synthesis of novel citrate-based siderophores and siderophore-.beta.-lactam conjugates. Iron transport-mediated drug delivery systems
    作者:Arun Ghosh、Marvin J. Miller
    DOI:10.1021/jo00079a007
    日期:1993.12
    The synthesis of analogs of arthrobactin (5), a microbial iron chelator, and its imide 8 are described. The differentially protected citric acid residue 31 served as the key intermediate in making conjugates having a generalized structure 14 with two representative carbacephalosporin units, 15 and 16. Both conjugates, 49 and 51, showed antibiotic activity, while conjugate 51 obtained from beta-lactam 16 bearing a phenylglycyl side chain was shown to be more effective.
  • Synthesis and Biological Evaluation of New Citrate-Based Siderophores as Potential Probes for the Mechanism of Iron Uptake in Mycobacteria
    作者:Hongyan Guo、Saleh A. Naser、George Ghobrial、Phanstiel
    DOI:10.1021/jm0104522
    日期:2002.5.1
    Several iron chelators containing alpha,beta-unsaturated hydroxamic acid motifs appended to a citric acid platform were synthesized. Mycobacterium paratuberculosis was then challenged to grow in the presence of a panel of siderophores (mycobactin J, deferrioxamine B, acinetoferrin, and nannochelin A) and the new synthetic agents. Of the structures tested, those containing the trans 2-octenoyl motif were preferred over those with trans cinnamoyl groups. In addition, derivatives containing longer tether lengths between the iron binding ligands (C5) were more efficacious and led to higher growth index values. Perhaps most remarkable was the finding that at 2.4 muM a trans 2-octenoylated, citrate-containing imide 6 was nearly 5-fold more effective in stimulating growth than the native chelator, mycobactin J. In this regard, new structural elements were identified (e.g., an imide motif or 2-octenoyl side chain), whose presence stimulated mycobacterial growth.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸